MedTrace Logo

The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

NCT03480854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 694

Last updated 2021-05-07

No results posted yet for this study

Summary

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

Conditions

Interventions

OTHER

Quality Improvement

Randomly selected sites will receive one of two system level improvement approaches; 1) patient centered specialty medical home certification 2) IHI Breakthrough Series improvement approach with professional improvement coaching.

Sponsors & Collaborators

  • MGH Multiple Sclerosis Clinic

    collaborator UNKNOWN

  • University of Vermont

    collaborator OTHER

  • Neurology Associates Multiple Sclerosis Center of Greater Orlando

    collaborator UNKNOWN

  • Concord Hospital

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Brant J Oliver, PhD · Dartmouth Hitchock

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480854 on ClinicalTrials.gov